A61K 47/558
The modifying agent being a chemiluminescent acceptor
Official title: {the modifying agent being a chemiluminescent acceptor}
A61K47/558 (The modifying agent being a chemiluminescent acceptor) appears on 38 US grants and 44 published applications in this corpus.
Search patents in A61K- Granted patents
- 38
- Published applications
- 44
- Assignees
- 31
- Inventors
- 90
- Latest grant
- 16 Sep 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 2 | 0 |
| 1996 | 3 | 0 |
| 1997 | 2 | 0 |
| 1998 | 3 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 1 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 1 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 5 |
| 2015 | 0 | 0 |
| 2016 | 3 | 4 |
| 2017 | 0 | 6 |
| 2018 | 8 | 2 |
| 2019 | 2 | 6 |
| 2020 | 0 | 2 |
| 2021 | 3 | 3 |
| 2022 | 0 | 3 |
| 2023 | 3 | 5 |
| 2024 | 3 | 3 |
| 2025 | 1 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Organic anion transporting peptide-based cancer imaging and therapy16 Sep 2025US 12,414,996 B2Da Zen Theranostics, Inc.
- Folate receptor targeted nanoparticle drug conjugates and uses thereof16 Apr 2024US 11,957,760 B2Elucida Oncology, Inc.
- Sonodynamic therapy23 Jan 2024US 11,878,059 B2University of Ulster
- Bio-orthogonal drug activation2 Jan 2024US 11,857,636 B2Tagworks Pharmaceuticals B.V.
- Triplet-triplet annihilation upconversion system, and compositions and methods thereof for drug delivery28 Nov 2023US 11,827,655 B2University of Massachusetts
- Prodrugs Based On Tumor Targeting Near Infrared Dye-Drug Conjugates (DDC)25 Dec 2025US 2025/0387494 A1Lahjavida, LLC
- Phosphinate ester-containing dyes having tunable properties and methods of making the same18 Jul 2024US 2024/0239823 A1NUtech Ventures
- Bio-orthogonal drug activation21 Mar 2024US 2024/0091371 A1Tagworks Pharmaceuticals B.V.
- Methods, compounds, and compositions for modifying car-t cell activity22 Feb 2024US 2024/0058458 A1
- Small molecule drug conjugates30 Nov 2023US 2023/0381324 A1Eidgenoessiche Technische Hochschule Zurich
Most cited
By later US patents
- Texaphyrin solid supports and devices47US 5,594,136 ABoard of Regents, The University of Texas · 1997
- Sapphyrins, derivatives and syntheses37US 5,302,714 ABoard of Regents, The University of Texas System · 1994
- Pro drugs for selective drug delivery32US 5,773,592 A1998
- Bio-orthogonal drug activation27US 9,421,274 B2Koninklijke Philips N. V. · 2016
- Sapphyrins, derivatives and syntheses24US 5,159,065 ABoard of Regents, The University of Texas System · 1992